Neurokinin-1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report.
Neurokinin-1 receptor antagonists in lung cancer therapy [Review of Neurokinin-1 receptor antagonists in lung cancer therapy].
The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines.
Cerrar
